For example aberrant expression of transcripts in the H19-IGF2 domain has been reported in more than 15 tumor types, with somatic amplifications of IGF2 and miR483 implicated in the initiation of colorectal cancer5, 6, with copy-number gains being mutually exclusive with P13K pathway-activating mutations7. The gene discussed is IGF2; the disease is neoplasm.